Ao-Qiu Chen
Research Subjects
Ao-Qiu Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jian-Lin Shen1 shared publication
- Jiang-Hong Luo1 shared publication
- Jin-Shi Chen1 shared publication
- Jing Li1 shared publication
- Qi Zou
School of Public Health and Health Management, Gannan Medical University, Ganzhou 341000, China
1 shared publication - Xiao-Fan Lin1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Transcriptomic and Proteomic Analyses Reveal the Anti–Ovarian Cancer Activity of Lotus Seedpod Polysaccharide on SKOV3 Cells via RIPK1/RIPK3/MLKL Pathway
This study aimed to investigate the anti–ovarian cancer activity of lotus seedpod polysaccharide (LSP) on human ovarian cancer SKOV3 cells and the relevant molecular mechanisms. The toxicity of LSP was also assessed in normal mice. The results showed that LSP inhibited SKOV3 proliferation and induced cell apoptosis. Transcriptomic and proteomic analyses indicated that LSP induced significant changes in gene and protein expressions, and their combined analysis showed necroptosis as one of the main pathways, which was confirmed by Hoechst 33342/PI double staining and western blot analysis. Moreover, LSPs significantly upregulated the protein expressions of RIPK1, phospho‐RIPK1, RIPK3, phospho‐RIPK3, MLKL, phospho‐MLKL, TNFRSF1A, FTH1, and FTL. Meanwhile, LSP increased ΔΨm loss and the ROS level in SKOV3 cells. Furthermore, LSP showed no acute toxicity to normal mice in the dose range of 50–450 mg/kg·bw. These results suggest that LSP is a safe active ingredient that exerts anti–ovarian cancer activity in SKOV3 cells by inhibiting proliferation, inducing cell apoptosis, and inducing necroptosis via the RIPK1/RIPK3/MLKL pathway. These findings are helpful to the application of LSP in anti–ovarian cancer and the high‐value utilization of lotus seedpod resources.
- 1 January 2025
- Published by Wiley in Journal of Food Biochemistry
- Vol. 2025 (1)
Open AccessTranscriptomic and Proteomic Analyses Reveal the Anti–Ovarian Cancer Activity of Lotus Seedpod Polysaccharide on SKOV3 Cells via RIPK1/RIPK3/MLKL Pathway
This study aimed to investigate the anti–ovarian cancer activity of lotus seedpod polysaccharide (LSP) on human ovarian cancer SKOV3 cells and the relevant molecular mechanisms. The toxicity of LSP was also assessed in normal mice. The results showed that LSP inhibited SKOV3 proliferation and induced cell apoptosis. Transcriptomic and proteomic analyses indicated that LSP induced significant changes in gene and protein expressions, and their combined analysis showed necroptosis as one of the main pathways, which was confirmed by Hoechst 33342/PI double staining and western blot analysis. Moreover, LSPs significantly upregulated the protein expressions of RIPK1, phospho‐RIPK1, RIPK3, phospho‐RIPK3, MLKL, phospho‐MLKL, TNFRSF1A, FTH1, and FTL. Meanwhile, LSP increased ΔΨm loss and the ROS level in SKOV3 cells. Furthermore, LSP showed no acute toxicity to normal mice in the dose range of 50–450 mg/kg·bw. These results suggest that LSP is a safe active ingredient that exerts anti–ovarian cancer activity in SKOV3 cells by inhibiting proliferation, inducing cell apoptosis, and inducing necroptosis via the RIPK1/RIPK3/MLKL pathway. These findings are helpful to the application of LSP in anti–ovarian cancer and the high‐value utilization of lotus seedpod resources.